BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

643 related articles for article (PubMed ID: 31855054)

  • 1. Emergence of extended-spectrum β-lactamase (ESBL) and/or carbapenemase producing Enterobacteriaceae (CPE) and their antimicrobial resistance.
    Koren J; Hubenakova Z; Drahovska H; Ozaee E; Markuskova B; Lichvarikova A
    Bratisl Lek Listy; 2019; 120(12):935-940. PubMed ID: 31855054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
    Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG;
    J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular epidemiology and clinical features of extended-spectrum beta-lactamase- or carbapenemase-producing Escherichia coli bacteremia in Japan.
    Komatsu Y; Kasahara K; Inoue T; Lee ST; Muratani T; Yano H; Kirita T; Mikasa K
    PLoS One; 2018; 13(8):e0202276. PubMed ID: 30157275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo study assessed meropenem and amikacin combination therapy against carbapenem-resistant and carbapenemase-producing Enterobacteriaceae strains.
    Hagihara M; Kato H; Yamashita R; Soda M; Watanabe H; Sakanashi D; Shiota A; Asai N; Koizumi Y; Suematsu H; Yamagishi Y; Kitaichi K; Mikamo H
    J Infect Chemother; 2020 Jan; 26(1):1-7. PubMed ID: 31735629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aztreonam-Avibactam Combination Restores Susceptibility of Aztreonam in Dual-Carbapenemase-Producing Enterobacteriaceae.
    Chew KL; Tay MKL; Cheng B; Lin RTP; Octavia S; Teo JWP
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760136
    [No Abstract]   [Full Text] [Related]  

  • 6. Emergence of High Prevalence of Extended-Spectrum Beta-Lactamase and Carbapenemase-Producing
    Tadesse S; Mulu W; Genet C; Kibret M; Belete MA
    Biomed Res Int; 2022; 2022():5727638. PubMed ID: 35155675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of Ceftazidime-Avibactam against Extended-Spectrum- and AmpC β-Lactamase-Producing Enterobacteriaceae Collected in the INFORM Global Surveillance Study from 2012 to 2014.
    Karlowsky JA; Biedenbach DJ; Kazmierczak KM; Stone GG; Sahm DF
    Antimicrob Agents Chemother; 2016 May; 60(5):2849-57. PubMed ID: 26926635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of multidrug-resistant Enterobacteriaceae in Sri Lanka: First evidence of bla
    Kumudunie WGM; Wijesooriya LI; Namalie KD; Sunil-Chandra NP; Wijayasinghe YS
    J Infect Public Health; 2020 Sep; 13(9):1330-1335. PubMed ID: 32439355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of extended-spectrum β-lactamase- and carbapenemase-producing Enterobacteriaceae Isolates from rivers and lakes in Switzerland.
    Zurfluh K; Hächler H; Nüesch-Inderbinen M; Stephan R
    Appl Environ Microbiol; 2013 May; 79(9):3021-6. PubMed ID: 23455339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characteristics of carbapenemase-producing Enterobacterales in the Netherlands; results of the 2014-2018 national laboratory surveillance.
    van der Zwaluw K; Witteveen S; Wielders L; van Santen M; Landman F; de Haan A; Schouls LM; Bosch T;
    Clin Microbiol Infect; 2020 Oct; 26(10):1412.e7-1412.e12. PubMed ID: 32006688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of fecal carriage of Extended-spectrum beta-lactamase and carbapenemase-producing Enterobacteriaceae among food handlers at the University of Gondar, Northwest Ethiopia.
    Amare A; Eshetie S; Kasew D; Moges F
    PLoS One; 2022; 17(3):e0264818. PubMed ID: 35298493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Gastrointestinal Colonization Rate with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Hospitalized Patients: Emergence of Carbapenemase-Producing K. pneumoniae in Ethiopia.
    Desta K; Woldeamanuel Y; Azazh A; Mohammod H; Desalegn D; Shimelis D; Gulilat D; Lamisso B; Makonnen E; Worku A; Mannerqvist K; Struwe J; Aspevall O; Aklillu E
    PLoS One; 2016; 11(8):e0161685. PubMed ID: 27574974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended-spectrum beta-lactamase (ESBL)- and carbapenemase-producing Enterobacteriaceae in water sources in Lebanon.
    Diab M; Hamze M; Bonnet R; Saras E; Madec JY; Haenni M
    Vet Microbiol; 2018 Apr; 217():97-103. PubMed ID: 29615264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamic evaluation of meropenem, cefepime, or aztreonam combined with a novel β-lactamase inhibitor, nacubactam, against carbapenem-resistant and/or carbapenemase-producing Klebsiella pneumoniae and Escherichia coli using a murine thigh-infection model.
    Hagihara M; Kato H; Sugano T; Okade H; Sato N; Shibata Y; Sakanashi D; Asai N; Koizumi Y; Suematsu H; Yamagishi Y; Mikamo H
    Int J Antimicrob Agents; 2021 May; 57(5):106330. PubMed ID: 33789129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmid-mediated quinolone resistance among extended spectrum beta lactase producing Enterobacteriaceae from bloodstream infections.
    Domokos J; Kristóf K; Szabó D
    Acta Microbiol Immunol Hung; 2016 Sep; 63(3):313-323. PubMed ID: 27539331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of specific inhibitors on metallo-β-carbapenemases detected in Escherichia coli and Klebsiella pneumoniae isolates.
    Abbas HA; Kadry AA; Shaker GH; Goda RM
    Microb Pathog; 2019 Jul; 132():266-274. PubMed ID: 31096002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bloodstream infections due to carbapenemase-producing Enterobacteriaceae in Italy: results from nationwide surveillance, 2014 to 2017.
    Iacchini S; Sabbatucci M; Gagliotti C; Rossolini GM; Moro ML; Iannazzo S; D'Ancona F; Pezzotti P; Pantosti A
    Euro Surveill; 2019 Jan; 24(5):. PubMed ID: 30722813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic and genotypic distribution of ESBL, AmpC β-lactamase and carbapenemase-producing Enterobacteriaceae in community-acquired and hospital-acquired urinary tract infections in Sri Lanka.
    Perera PDVM; Gamage S; De Silva HSM; Jayatilleke SK; de Silva N; Aydin A; Enne VI; Corea EM
    J Glob Antimicrob Resist; 2022 Sep; 30():115-122. PubMed ID: 35667644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic and Genotypic Characterization of Carbapenem-resistant Enterobacteriaceae: Data From a Longitudinal Large-scale CRE Study in China (2012-2016).
    Wang Q; Wang X; Wang J; Ouyang P; Jin C; Wang R; Zhang Y; Jin L; Chen H; Wang Z; Zhang F; Cao B; Xie L; Liao K; Gu B; Yang C; Liu Z; Ma X; Jin L; Zhang X; Man S; Li W; Pei F; Xu X; Jin Y; Ji P; Wang H
    Clin Infect Dis; 2018 Nov; 67(suppl_2):S196-S205. PubMed ID: 30423057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistance.
    Ku YH; Chen CC; Lee MF; Chuang YC; Tang HJ; Yu WL
    J Microbiol Immunol Infect; 2017 Dec; 50(6):931-939. PubMed ID: 28716360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.